Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy

International Journal of Urology

Volumn 9, Issue 10, 2002, Pages 539-544

  Nonomura, N ^a   Nishimura, K ^a   Takaha, N ^a   Inoue, H ^a   Nomoto, T ^b   Mizutani, Y ^b   Nakao, M ^b   Okuyama, A ^b   Miki, T ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Germ cell tumor; Nerve sparing retroperitoneal lymph node dissection; Testicular cancer

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; EJACULATION; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; METASTASIS; NERVE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; RISK ASSESSMENT; SEMINOMA; SPLANCHNIC NERVE; STEM CELL TRANSPLANTATION; TESTIS CARCINOMA; ADOLESCENT; LYMPHADENECTOMY; MALE; METHODOLOGY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; NEOPLASM; RETROPERITONEUM; SEXUAL DYSFUNCTION; TESTIS TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROPERITONEAL SPACE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 0036434761     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2002.00520.x     Document Type: Article

References (15)

1. Donohue JP, Rowland RG. Complications of retroperitoneal node dissection. J. Urol. 1981; 125: 338-40.
2. Narayan P, Lange PH, Fraley EE. Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer. J. Urol. 1982; 127: 685-8.
3. Arai Y, Kawakita M, Okada Y, Yoshida O. Sexuality and fertility in long-term survivors of testicular cancer. J. Clin. Oncol. 1997;15: 1444-8.
4. Jewett MA, Kang SP, Goldberg SD et al. Retroperitoneal lymphadenectomy for testis tumor with nerve-sparing for ejaculation. J. Urol. 1988;139: 1220-4.
5. Colleselli K, Poisel S, Schachter W, Bartsch G. Nerve-preserving bilateral retroperitoneal lymphadenectomy: Anatomical study and operative approach. J. Urol. 1990; 144: 293-8.
6. Donohue JP, Foster RS, Rowland RG, Bihrle R, Jones D, Geier G. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J. Urol. 1990;144: 287-92.
7. Lange PH, Chang WY, Fraley EE. Fertility issues in the treatment of nonseminomatous testicular tumors. Urol. Clin. North Am. 1987;14: 731-47.
8. Wahle GR, Foster RS, Bihrle R, Rowland RG, Bennet RM, Donohue JP. Nerve-sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma. J. Urol. 1994; 152: 428-31.
9. Solsona E, Iborra I, Ricos JV et al. Preservation of antegrade ejaculation in retroperitoneal lymphadenectomy due to residual masses after primary chemotherapy for testicular carcinoma. Eur. Urol. 1994;25: 199-203.
10. Coogan CL, Hejase JH, Wahle GR et al. Nerve-sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer. J. Urol. 1996;156: 1656-8.
11. The Japanese Urological Association and the Japanese Pathological Society. General Rules for Clinical and Pathological Studies on Testicular Tumors, 2nd Edn. Kanehara Shuppan, Tokyo, 1997 (in Japanese).
12. Skinner EC, Skinner DG. Surgery of testicular neoplasms. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds). Campbell's Urology, 7th Edn. WB Saunders, Philadelphia, 1998: 3410-32.
13. Arai Y, Ishitoya S, Kazutoshi O et al. Nerve-sparing retroperitoneal lymph node dissection for metastatic testicular cancer. Int. J. Urol. 1997;4: 487-92.
14. Drasga RE, Einhorn LH, Williams SD, Patel DN, Stevens EE. Fertility after chemotherapy for testicular cancer. J. Clin. Oncol. 1983;1: 179-83.
15. Boyer M, Raghaven D. Toxicity of treatment of germ cell tumors. Semin. Oncol. 1992;19: 128-42.